Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

AMN Healthcare Services is viewed favorably because Q1 results materially beat expectations, with revenue up 100% y/y to $1,378M, adjusted EBITDA of $166M exceeding consensus by 35%, and margins expanding to 12.1%, showing strong operating leverage. The core Nurse and Allied segment appears to be stabilizing and resuming growth, helped by 9.2K travelers, 6% higher bill rates, and a 5% sequential increase excluding labor disruption and rapid response revenue, while international nursing is recovering and is expected to return to mid-to-high-teens growth in 2026. The balance sheet also looks manageable, with net leverage at 1.6x and expected to remain at 2x or less through the remainder of the year, supporting acquisitions, margin expansion, and a potential return to normalized growth by 2027.

Bears say

AMN Healthcare Services is facing deteriorating fundamentals as management expects Q2 segment revenue to be flat to down 2% Y/Y, with ex-labor disruption revenue implying an 8% to 10% sequential decline from Q1, while Physician and Leadership revenue already fell 6% to $164M and gross margin compressed 120 bps Y/Y to 26.1%. The company’s core staffing engine is weakening, with organic segment revenue down 4% in 2025 after rising 9% in 2024 and projected to fall another 4% in 2026, while VMS revenue has collapsed at a (35%) CAGR from 2022 to 2025 amid secular pressure toward core hiring over temporary labor. Heavy leverage, with nearly $1B in debt, compounds the risk because declining revenue and margin compression reduce flexibility to service obligations, and the business also faces exposure to nurse recruitment/retention, contract labor demand, and customer concentration risk.

AMN has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 5 analysts, AMN has a Buy consensus rating as of Oct 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.